New subset of T cells may enhance cancer immunotherapy

FHS
May 28, 2024
5:59 pm

A team of cancer researchers, led by the University of Houston, has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.

A Blueprint for Solving the U.S. Nursing Shortage Crisis

Andy Coville, CEO, Brodeur Partners Alice Holland, Ph.D., NP-C, CSE Nurses have the highest level of public trust across medical professions, yet there’s a huge

August 23, 2023

Treatment of Tardive Dyskinesia

Experts and guidelines recommend vesicular monoamine 2 transporter (VMAT2) inhibitors as the best option for treating more severe cases of tardive dyskinesia, an involuntary movement

August 14, 2024

Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant

Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021,

March 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.